
1. biomed res int. 2017;2017:3428186. doi: 10.1155/2017/3428186. epub 2017 jul 19.

reduction mosquito survival mice vaccinated anopheles stephensi
glucose transporter.

couto j(1), antunes s(1), ferrolho j(1), de la fuente j(2)(3), domingos a(1).

author information: 
(1)global health tropical medicine, instituto de higiene e medicina,
universidade nova de lisboa (ghmt-ihmt-unl), rua da junqueira 100, 1349-008
lisboa, portugal.
(2)sabio, instituto de investigación en recursos cinegéticos (irec),
csic-uclm-jccm, ronda de toledo s/n, 13005 ciudad real, spain.
(3)department veterinary pathobiology, center veterinary health sciences, 
oklahoma state university, stillwater, ok 74078, usa.

despite fact recent efforts control/eradicate malaria have
contributed significant decrease number cases deaths, the
disease remains global health challenge. vaccines based mosquito salivary
gland antigens potential approach reducing vector populations and
malaria parasites. anopheles agap007752 gene encodes glucose
transporter upregulated plasmodium infection, knockdown
decreases number sporozoites mosquito salivary glands. results
together fact glucose vital source energy suggested 
glucose transporter candidate protective antigen control mosquito
infestations plasmodium infection. address hypothesis, herein we
investigate effect mice vaccination immunogenic peptide from
mosquito glucose transporter anopheles stephensi fitness plasmodium
berghei infection. showed vaccination peptide glucose
transporter reduced mosquito survival 5% compared controls. however,
the reduction plasmodium infection significant mosquitoes fed on
vaccinated mice. effect peptide vaccination mosquito survival is
important reduce infestation malaria vectors. results support further
research developing glucose transporter-based vaccines reduce mosquito
fitness.

doi: 10.1155/2017/3428186 
pmcid: pmc5540378
pmid: 28804714  [indexed medline]

